Page last updated: 2024-10-21

phenytoin and Bone Diseases, Developmental

phenytoin has been researched along with Bone Diseases, Developmental in 2 studies

Bone Diseases, Developmental: Diseases resulting in abnormal GROWTH or abnormal MORPHOGENESIS of BONES.

Research Excerpts

ExcerptRelevanceReference
" Seventy-six children of the study group had been exposed to phenytoin in the first 20 weeks of pregnancy, 21 had been exposed to other anti-epileptic drugs excluding phenytoin, and 14 had not been exposed."3.68Distal phalangeal hypoplasia in children with prenatal phenytoin exposure: results of a controlled anthropometric study. ( Gaily, E, 1990)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gaily, E1
Satoyoshi, E1

Other Studies

2 other studies available for phenytoin and Bone Diseases, Developmental

ArticleYear
Distal phalangeal hypoplasia in children with prenatal phenytoin exposure: results of a controlled anthropometric study.
    American journal of medical genetics, 1990, Volume: 35, Issue:4

    Topics: Anthropometry; Bone Diseases, Developmental; Child, Preschool; Dose-Response Relationship, Drug; Fem

1990
Recurrent muscle spasms of central origin.
    Transactions of the American Neurological Association, 1967, Volume: 92

    Topics: Bone Diseases, Developmental; Brain Diseases; Carbohydrate Metabolism, Inborn Errors; Child; Diarrhe

1967